These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 9059966)

  • 1. Cholestasis associated with mesalazine therapy in a patient with Crohn's disease.
    Stoschus B; Meybehm M; Spengler U; Scheurlen C; Sauerbruch T
    J Hepatol; 1997 Feb; 26(2):425-8. PubMed ID: 9059966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mesalazine-induced eosinophilic pneumonia in a patient with Crohn's disease].
    Park JE; Hwangbo Y; Chang R; Chang YW; Jang JY; Kim BH; Dong SH; Kim HJ
    Korean J Gastroenterol; 2009 Feb; 53(2):116-20. PubMed ID: 19237838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mesalazine and sulphasalazine for Crohn's disease: few indications, severe adverse reactions].
    Uittenbogaart SB; Klemt-Kropp M
    Ned Tijdschr Geneeskd; 2011; 155(48):A3842. PubMed ID: 22152414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hypersensitivity to 5-aminosalicylic acid. Value of desensitization by oral route].
    Lachaux A; Le Gall C; Loras-Duclaux I; Aboufadel A; Hermier M
    Arch Pediatr; 1997 Feb; 4(2):144-6. PubMed ID: 9097825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diffuse alopecia as side effect of mesalazine therapy in Crohn's disease].
    Netzer P
    Schweiz Med Wochenschr; 1995 Dec; 125(50):2438-42. PubMed ID: 8553032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-Aminosalicylic acid-associated renal tubular acidosis with decreased renal function in Crohn's disease.
    Hämling J; Raedler A; Helmchen U; Schreiber S
    Digestion; 1997; 58(3):304-7. PubMed ID: 9243128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crohn's Disease with Mesalazine Allergy that Was Difficult to Differentiate from Comorbid Ulcerative Colitis.
    Tsuboi R; Matsumoto S; Miyatani H; Mashima H
    Intern Med; 2019 Mar; 58(5):649-654. PubMed ID: 30333413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Acute renal failure associated with 5-aminosalicylic acid in inflammatory bowel disease].
    García-Díaz M; Nevado L; Berenguer A; Bureo JC; Bureo P; Sáenz de Santamaría J
    Gastroenterol Hepatol; 1995 Jan; 18(1):18-21. PubMed ID: 7621266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pneumonitis caused by mesalazine].
    Pascual Lledó F; Calvo Bonachera J; Carrasco Miras F; Sánchez-Martínez H
    Arch Bronconeumol; 1997 Jun; 33(6):309-11. PubMed ID: 9289328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "Hepatotoxicity in inflammatory bowel disease: mesalazine, the forgotten drug".
    Garrido I; Santos AL; Lopes J; Lopes S; Macedo G
    Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e1067-e1070. PubMed ID: 35048663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sulfasalazine, 5-ASA and acute pancreatitis in crohn's disease.
    Debongnie JC; Dekoninck X
    J Clin Gastroenterol; 1994 Dec; 19(4):348-9. PubMed ID: 7876525
    [No Abstract]   [Full Text] [Related]  

  • 12. Sulfasalazine and mesalazine for the maintenance therapy of Crohn's disease: a meta-analysis.
    Steinhart AH; Hemphill D; Greenberg GR
    Am J Gastroenterol; 1994 Dec; 89(12):2116-24. PubMed ID: 7977225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of mesalazine in Crohn's disease.
    Hanauer SB
    Scand J Gastroenterol Suppl; 1990; 172():56-9. PubMed ID: 1972296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolonged-release mesalazine: a review of its therapeutic potential in ulcerative colitis and Crohn's disease.
    Clemett D; Markham A
    Drugs; 2000 Apr; 59(4):929-56. PubMed ID: 10804042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mesalazine].
    Netzer P
    Dtsch Med Wochenschr; 1996 Jan; 121(1-2):42. PubMed ID: 8565806
    [No Abstract]   [Full Text] [Related]  

  • 16. Hypersensitivity with hepatotoxicity to mesalazine after hypersensitivity to sulfasalazine.
    Hautekeete ML; Bourgeois N; Potvin P; Duville L; Reynaert H; Devis G; Adler M; Klöppel G
    Gastroenterology; 1992 Dec; 103(6):1925-7. PubMed ID: 1360436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pentasa (mesalazine) and pregnancy].
    Jonville-Bera AP; Soyez C; Fignon A; Moraine C; Berger C; Autret E
    Therapie; 1994; 49(5):443-5. PubMed ID: 7855761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous hypersensitivity reaction to mesalazine.
    Aparicio J; Carnicer F; Girona E; Gmez A
    Am J Gastroenterol; 1996 Mar; 91(3):620-1. PubMed ID: 8633534
    [No Abstract]   [Full Text] [Related]  

  • 19. Mesalazine-induced Pleuropericarditis in a Patient with Crohn's Disease.
    Kiyomatsu H; Kawai K; Tanaka T; Tanaka J; Kiyomatsu T; Nozawa H; Kanazawa T; Kazama S; Ishihara S; Yamaguchi H; Sunami E; Watanabe T
    Intern Med; 2015; 54(13):1605-8. PubMed ID: 26134190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesalazine as a maintenance treatment in Crohn's disease: is it the long awaited solution?
    Sahmoud T; Mary JY; Sahmoud T
    Gut; 1997 Feb; 40(2):284-5. PubMed ID: 9071946
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.